Vascular Closure Devices Market - Latest Trends & Insights 2024

Vascular Closure Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 2024 Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Vascular Closure Devices Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Vascular access site complications following catheterization procedures are one of the most frequent causes of morbidity.

Manual compression is the most commonly followed procedure in achieving hemostasis of the arterial site. However manual compression frequently requires anticoagulation, prolonged bed rest and patient discomfort, along with time constraints for healthcare providers. Vascular closure devices (VCDs) have emerged as an alternative to mechanical compression in order to reduce the hemostasis that includes biodegradable plugs, sutures, staples or ultrasound.

Vascular closure devices offer advantages over manual compression in terms of patient easiness, reduction in ambulation period, and clotting time, however complications

related to the femoral site are still present. The main goal is to prevent vascular access site complications, and achieving rapid hemostasis. These are effective and well tolerated in the procedures that do not use anti coagulation and in diagnostic procedures. Due to the several advantages of VCDs over the traditional mode of hemostasis, they are widely used in both diagnostic and interventional procedures.

Browse Full Research Report on Vascular Closure Devices Market: http://www.transparencymarketresearch.com/vascularclosure-devices-market.html Various types of vascular closures are developed over a period of time that incorporate different mechanisms. The safety of VCDs remains in uncertainty as they may rise the risk of infection and leg ischemia. The benefits conveyed by VCDs are supposed to be costly; particularly in case of invasive VCDs. The increasing desire for radial access in the coronary procedures, is a major concern for VCDs market, as the radial artery can be closed more easily, thus opposing the need for invasive VCDs. This could also result in a swing from invasive VCDs to the low-priced manual compression device.

The inherent vascular closure device market has been segmented by types of devices and geography. The types of devices include the manual compression and vascular closure devices. The

VCDs are of two types: active and passive. Passive VCDs provide enhanced hemostasis with mechanical compression but do not give prompt hemostasis. The passive VCDs are further classified as hemostatic pad,(Chito seal, CloSur pad, Neptune pad, Syvek patch and Dstat), and compression devices (femostop system, compass system, clamp ease, safeguard dressing and x press device).

Active VCDs are categorized as suture devices, clips, polyglycolic acid devices, and collagen plug devices. Collagen plug devices consist of two type’s angioseal and vasoseal whereas polyglycolic acid consists of mynx and exoseal. Based on the geography the VCDs can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

An increasing range of endovascular procedures, preference for minimal invasive surgeries, decrease in the rate of vascular complications after the use of VCDs (angioseal and perclose), increasing catheterization related procedures, reimbursement for diagnostic procedures carried out, ease in usage and quick hemostatic properties of VCDs, and comfort provided to the patients are the major factors responsible to drive the market of VCDs.

The increasing cost of implantable vascular devices, complications associated with VCD, low adoption of advance technology in the emerging countries, the rising incidences of leg ischemia, growing infection has resulted in decline in VCDs market. The number of peripheral vascular procedures is increasing yearly, leading to sustainment and stabilization of the market of invasive VCDs.

The major players in VCDs are St. Jude Medical, Morris Innovative Research, Vascular Solutions, Abbott Laboratories, Cardiva Medical, Cardinal Health, Marine Polymer Technologies, Terumo Corporation, Advanced Vascular Dynamics, Benrikal Services, Scion BioMedical. St Jude’s is the leader in the global vascular closure devices market.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com